|
|||||
|
|
||||||
© 2003 American Society for Clinical Oncology
Diagnostic Challenges in Patients With TumorsCASE 3. NORMAL-SIZED OVARIAN CANCER DETECTED BY COLOR DOPPLER ULTRASOUND USING A MICROBUBBLE CONTRAST AGENTFukuoka University Medical School, Fukuoka, Japan
A 58-year-old postmenopausal woman first visited our gynecologic clinic with a high serum CA 19-9 value (3,483 U/mL) owing to an unknown cause. The serum CA-125 value was 28 U/mL (normal level, < 35 U/mL). In her previous clinical examinations, no evidence of a tumor was found on chest or abdominal computed tomography scans, abdominal ultrasound, or gallium-67 scintigraphy. The patient had no history of any gynecologic disorders. A bimanual vaginal examination revealed a normal uterus without any adnexal enlargement. Both ovaries were confirmed to be of normal size, and a small cyst measuring 24 x 20 mm in size was detected in the left ovary by transvaginal gray-scale ultrasound. Magnetic resonance imaging showed a small cyst, 26 x 21 mm in size, in her left ovary (Fig 1
In the field of gynecology, an uncommon clinical phenomenon has been reported in which diffuse metastatic disease of the peritoneal cavity coexists with ovaries that are grossly normal in size and may demonstrate some granularity on their external surface. This phenomenon has been called a normal-sized ovary carcinoma syndrome.5 However, the current case is considered to be a normal-sized ovarian carcinoma at a truly early stage. The infusion of a microbubble contrast-agent can therefore greatly increase the diagnostic value of a color Doppler examination by increasing the intensity of weak signals to a detectable level.6 Recent studies have shown the usefulness of contrast-enhanced sonography in the early detection of cancer or differentiating malignant from benign lesions.79 To our knowledge, this may be the first case in which a normal-sized ovarian cancer at an early stage was preoperatively diagnosed by imaging. AUTHORS DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The authors indicated no potential conflicts of interest.
REFERENCES 1. Bourne T, Campbell S, Steer C, et al: Transvaginal colour flow imaging: A possible new screening technique for ovarian cancer. BMJ 299:13671370, 1989[Medline] 2. Kurjak A, Zalud I, Alfirevic Z, et al: Evaluation of adnexal masses with transvaginal color ultrasound. J Ultrasound Med 10:295297, 1991[Abstract] 3. Fleisher AC, Cullinan JA, Peery CV, et al: Early detection of ovarian carcinoma with transvaginal color Doppler ultrasonography. Am J Obstet Gynecol 174:101106, 1996[CrossRef][Medline] 4. Emoto M, Iwasaki H, Mimura K, et al: Differences in angiogenesis of benign and malignant ovarian tumors, demonstrated by analyses of color Doppler ultrasound, immunohistochemistry, and microvessel density. Cancer 80:899907, 1997[CrossRef][Medline]
5. Feuer GD, Shevchuk M, Calanog A: Normal-sized ovary carcinoma syndrome. Obstet Gynecol 73:786792, 1989
6. Blomley MJ, Cooke JC, Unger EC, et al: Microbubble contrast agents: A new era in ultrasound. BMJ 322:12221225, 2001 7. Frauscher F, Klauser A, Halpern EJ, et al: Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet 357:18491850, 2001[CrossRef][Medline]
8. von Herbay A, Vogt C, Haussinger D: Late-phase pulse-inversion sonography using the contrast agent Levovist: Differentiation between benign and malignant focal lesions of the liver. Am J Roentgenol 179:12731279, 2002
9. Kupesic S, Kurjak A: Contrast-enhanced, three-dimensional power Doppler sonography for differentiation of adnexal masses. Obstet Gynecol 96:452458, 2000 This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|